$AXDX Next Target PTs 1.50-2-2.75 and higherAccelerate Diagnostics, Inc., an in vitro diagnostics company, provides solutions for the diagnosis of serious infections in the United States, Europe, and the Middle East. The company offers Accelerate Pheno system, an in vitro diagnostic platform for the identification and antibiotic susceptibilit
Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
−46.11 MXN
−1.04 B MXN
243.90 M MXN
15.31 M
About Accelerate Diagnostics, Inc.
Sector
Industry
CEO
Jack Phillips
Website
Headquarters
Tucson
Founded
1982
FIGI
BBG00PC2K423
Accelerate Diagnostics, Inc. is an in vitro diagnostics company, which engages in the provision of solutions that improve patient outcomes and lower healthcare costs through the rapid diagnosis of serious infections. The firm also focuses on developing and commercializing innovative instrumentation for the rapid identification and antibiotic susceptibility testing of infectious pathogens. Its products include Accelerate Pheno and Accelerate PhenoTest. The company was founded in 1982 and is headquartered in Tucson, AZ.
AXDX - Trading near the stronger supportAXDX is currently trading near the support at $5.34 and the stock has been holding weak since 2017. From the overlap indicators, we can see the bearish trend, at the moment, the price is below of 100 and 200 SMA from daily chart and below 20, 50, 100 and 200 SMA from weekly chart. The momentum indic
Short squeeze mini series#28Tips:
*** SPX'S Index is in a peak/correction mood!!!
***This could turn out to be, not a short
squeeze!! rather a crashing stock !!!
***Or my work could be just wrong !!!
What Is a Short Squeeze?
A short squeeze occurs when a stock or other
asset jumps sharply higher, forcing traders who
had be
#AXDX $AXDX Bout to squeeze like a lemon!This stock has a short ratio of over 60. Was over 100 recently so I am told, and the fixed range is showing a lot of buying in the last 3 days. There is some support building at this level dating back to April, not much price action below these levels unless you go back far on the monthly chart, w
See all ideas
Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Displays a symbol's price movements over previous years to identify recurring trends.
Related stocks
Frequently Asked Questions
The current price of AXDX is 14.31 MXN — it has decreased by −28.45% in the past 24 hours. Watch ACCELERATE DIAGNOSTICS INC stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on BMV exchange ACCELERATE DIAGNOSTICS INC stocks are traded under the ticker AXDX.
AXDX reached its all-time high on Jun 10, 2019 with the price of 4,066.00 MXN, and its all-time low was 14.31 MXN and was reached on Apr 3, 2025. View more price dynamics on AXDX chart.
See other stocks reaching their highest and lowest prices.
See other stocks reaching their highest and lowest prices.
AXDX stock is 39.76% volatile and has beta coefficient of 0.40. Track ACCELERATE DIAGNOSTICS INC stock price on the chart and check out the list of the most volatile stocks — is ACCELERATE DIAGNOSTICS INC there?
Today ACCELERATE DIAGNOSTICS INC has the market capitalization of 279.97 M, it has decreased by −18.82% over the last week.
Yes, you can track ACCELERATE DIAGNOSTICS INC financials in yearly and quarterly reports right on TradingView.
ACCELERATE DIAGNOSTICS INC is going to release the next earnings report on May 8, 2025. Keep track of upcoming events with our Earnings Calendar.
AXDX earnings for the last quarter are −7.34 MXN per share, whereas the estimation was −10.42 MXN resulting in a 29.62% surprise. The estimated earnings for the next quarter are −10.04 MXN per share. See more details about ACCELERATE DIAGNOSTICS INC earnings.
ACCELERATE DIAGNOSTICS INC revenue for the last quarter amounts to 58.38 M MXN, despite the estimated figure of 62.55 M MXN. In the next quarter, revenue is expected to reach 61.46 M MXN.
AXDX net income for the last quarter is −199.92 M MXN, while the quarter before that showed −288.44 M MXN of net income which accounts for 30.69% change. Track more ACCELERATE DIAGNOSTICS INC financial stats to get the full picture.
No, AXDX doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of Apr 24, 2025, the company has 107 employees. See our rating of the largest employees — is ACCELERATE DIAGNOSTICS INC on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. ACCELERATE DIAGNOSTICS INC EBITDA is −664.91 M MXN, and current EBITDA margin is −272.60%. See more stats in ACCELERATE DIAGNOSTICS INC financial statements.
Like other stocks, AXDX shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade ACCELERATE DIAGNOSTICS INC stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So ACCELERATE DIAGNOSTICS INC technincal analysis shows the strong sell today, and its 1 week rating is strong sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating ACCELERATE DIAGNOSTICS INC stock shows the strong sell signal. See more of ACCELERATE DIAGNOSTICS INC technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.